![1-(4-Chlorophenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-ca…](https://static.cymitquimica.com/products/TR/img/C429390.png "Click to enlarge")
1-(4-Chlorophenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide
CAS: 2029205-64-7
Ref. TR-C429390
| 1mg | 266.00 € | ||
| 10mg | 1,793.00 € |
Estimated delivery in United States, on Monday 29 Jul 2024
Product Information
Name:
1-(4-Chlorophenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide
Synonyms:
- 1-(4-Chlorophenyl)-4,5,6,7-tetrahydro-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
Description:
Applications 1-(4-Chlorophenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide is a reagent used in the preparation of SAR of apixaban derivatives as Fxa inhibitors.
References Wang, Y. et al.: Bio. & Med. Chem., 24(21), 5646-5661, (2016)
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
TRC
Long term storage:
Notes:
Chemical properties
Molecular weight:
465.93
Formula:
C24H24ClN5O3
Color/Form:
Off-White
InChI:
InChI=1S/C24H24ClN5O3/c25-15-4-6-18(7-5-15)30-22-19(21(27-30)23(26)32)12-14-29(24(22)33)17-10-8-16(9-11-17)28-13-2-1-3-20(28)31/h4-11,19,22H,1-3,12-14H2,(H2,26,32)
InChI key:
InChIKey=ZYESSUFXOVCECE-UHFFFAOYSA-N
SMILES:
NC(=O)C1=NN(c2ccc(Cl)cc2)C2C(=O)N(c3ccc(N4CCCCC4=O)cc3)CCC12
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TR-C429390 1-(4-Chlorophenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
